|Dr. Andreas Fouras M.A.I.C.D., Ph.D.||Founder, MD, CTO, CEO & Exec. Director||686.48k||N/A||N/A|
|Mr. John Andrew Livingston BAppSci, GradCertBus, GradDipHSc||Exec. Director||439.94k||N/A||N/A|
|Mr. Simon Glover||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Craige Pendleton-Browne B.Sc., M.B.A.||Chief Information Officer||N/A||N/A||N/A|
|Beth Plunkett||Company Legal Counsel||N/A||N/A||N/A|
|Mr. Clint Rodgers||VP of Marketing & Communications||N/A||N/A||N/A|
|Ms. Rachael Tenkaten||Chief of Staff||N/A||N/A||N/A|
|Mr. Paul Cooke B.A.||Sr. VP of Strategy & Bus. Devel.||N/A||N/A||N/A|
|Dr. Aidan Jamison B.E., Ph.D.||Sr. VP of Engineering||N/A||N/A||N/A|
|Dr. Michael Curtis Ph.D.||Chief Software Architect||N/A||N/A||N/A|
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
4DMedical Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.